NCT03038451View on ClinicalTrials.gov

Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 20, 2013

Primary Completion Date

February 14, 2017

Study Completion Date

February 14, 2017

Conditions
Hypertension
Interventions
DRUG

S-NOR (s-amlodipine) 2,5 mg & 5 mg tablet

Trial Locations (1)

34093

Istanbul University Istanbul Medical Faculty Clinical Pharmacology Department, Istanbul

All Listed Sponsors
lead

Neutec Ar-Ge San ve Tic A.Ş

INDUSTRY

NCT03038451 - Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients | Biotech Hunter | Biotech Hunter